|
RSPRY1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.006500E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.335500E-03 |
| Normal-vs-Stage2 |
7.159600E-03 |
| Normal-vs-Stage3 |
4.784100E-04 |
| Normal-vs-Stage4 |
9.622100E-04 |
| Stage1-vs-Stage2 |
5.062000E-01 |
| Stage1-vs-Stage3 |
1.254750E-01 |
| Stage1-vs-Stage4 |
1.684610E-01 |
| Stage2-vs-Stage3 |
5.679600E-01 |
| Stage2-vs-Stage4 |
5.822400E-01 |
| Stage3-vs-Stage4 |
9.916600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.476160E-03 |
| Normal-vs-AfricanAmerican |
1.635390E-01 |
| Normal-vs-Asian |
3.108400E-02 |
| Caucasian-vs-AfricanAmerican |
5.454400E-01 |
| Caucasian-vs-Asian |
9.205000E-01 |
| AfricanAmerican-vs-Asian |
6.391600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.716670E-03 |
| Normal-vs-Female |
3.523500E-03 |
| Male-vs-Female |
6.029400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.583900E-02 |
| Normal-vs-Age(41-60Yrs) |
9.996500E-04 |
| Normal-vs-Age(61-80Yrs) |
9.93559999999949E-05 |
| Normal-vs-Age(81-100Yrs) |
8.355700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.807900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.174200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.863590E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.210000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.641000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.387400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.806760E-01 |
| Classical-VS-Follicular |
1.557380E-03 |
| Classical-VS-Other |
2.440600E-01 |
| Classical-VS-Normal |
5.260000E-02 |
| Tall-VS-Follicular |
4.776200E-01 |
| Tall-VS-Other |
5.727600E-01 |
| Tall-VS-Normal |
4.119600E-03 |
| Follicular-VS-Other |
8.906600E-01 |
| Follicular-VS-Normal |
2.27359999999122E-05 |
| Other-VS-Normal |
2.645600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.209170E-04 |
| Normal-vs-N1 |
3.439200E-03 |
| N0-vs-N1 |
8.550800E-01 |
|
|
